Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ATRA | FIMM | pan-cancer | AAC | -0.056 | 0.7 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |